News
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q3 2022
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Dexcom Reports Third Quarter 2022 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2022.
Third Quarter 2022 Financial Highlights:
-
Revenue grew 18% versus the same
Labcorp Announces 2022 Third Quarter Results
Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year guidance.
"Labcorp made important strategic
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: MediClin AG: Disclosure of Significant Transactions with Related Parties pursuant to Section 111c of the German Stock Corporation Act (AktG)
Simulations Plus Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its fourth
Humana, Monogram Health Announce New Agreement that Enhances In-home Kidney Care in Four States
Kidney care provider Monogram Health and leading health and well-being company Humana Inc. (NYSE: HUM) have announced a new value-based care agreement for most Humana Medicare Advantage HMO and PPO
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
BIOCORP und NOVO NORDISK verstärken ihre Partnerschaft mit einer neuen Vereinbarung über den Mallya® Smart Sensor
BIOCORP (FR0012788065 - ALCOR / Eligible PEA-PME) (Paris:ALCOR), ein französisches Unternehmen, das auf das Design, die Entwicklung und die Herstellung innovativer medizinischer Geräte
BIOCORP and NOVO NORDISK Strengthen Their Partnership With a New Agreement on Mallya® Smart Sensor
Regulatory News:
BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME) (Paris:ALCOR), a French company specialized in the design, development, and manufacturing of innovative medical devices
MD Medical Group Investments Plc: Results of the Board of Directors meeting
EQS-Adhoc: MEDICLIN reaches agreement regarding early renewal of lease agreements for 20 clinic locations and settlement of lease dispute with (former) shareholders
Humana expands Medicare Advantage health plan offerings into Rhode Island, Wyoming and 140 new counties nationwide in 2023
Leading health and well-being company Humana Inc. (NYSE: HUM) is offering Medicare Advantage plans for the first time in two new states and 140 new U.S. counties, expanding cost-effective health
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Simulations Plus Announces Cash Dividend
Simulations Plus, Inc. (Nasdaq: SLP) announced today that the Company’s Board of Directors has declared a cash dividend of $0.06 per share of the Company’s common stock, payable on November 7
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
STAAR Surgical to Report Third Quarter Results on November 2, 2022
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release
Premier, Inc. Issues 2022 Sustainability Report
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today released its 2022 Sustainability Report detailing its companywide initiatives focused on
BD und BIOCORP unterzeichnen Vertrag, um Konnektivität und Rückverfolgbarkeit für selbst verabreichte Injektionspräparate zu schaffen
Regulatorische Nachrichten:
BD (Becton, Dickinson and Company) (NYSE: BDX), ein Weltmarktführer in der Medizintechnik, und Biocorp (Paris:ALCOR), ein in Frankreich ansässiger Hersteller von